08.11.2014 Views

Here - American Geriatrics Society

Here - American Geriatrics Society

Here - American Geriatrics Society

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

P APER<br />

A BSTRACTS<br />

ent. We hypothesize that resveratrol may be acting through SIRT-1,<br />

which in turn inhibits p53-regulated senescence. Because colon cancer<br />

is a disease whose incidence rises with age, the ability of resveratrol<br />

to inhibit senescence and the aging process in colonic mucosa will<br />

potentially have profound applicability to colon cancer prevention.<br />

P17<br />

The Role of SIRT3-dependent Autophagy in Age-Related<br />

Hearing Loss.<br />

I. Pena , F. A. Pereira. Huffington Center on Aging, Departments of<br />

Otolaryngology-HNS and Molecular & Cellular Biology, Baylor<br />

College of Medicine, Houston, TX.<br />

Supported By: <strong>American</strong> Federation for Aging Research / Medical<br />

Student Training in Aging Research Program, The Oticon<br />

Foundation / The <strong>American</strong> Academy of Otolaryngology–Head &<br />

Neck Surgery Foundation, Huffington Center on Aging–Baylor<br />

College of Medicine.<br />

Background: In 2005, the WHO estimated that 278 million people<br />

suffered moderate-to-profound hearing impairments. This number is<br />

expected to reach 900 million people by 2050, creating immense socioeconomic<br />

burdens worldwide. Age-related hearing loss (AHL), a<br />

disorder associated with accumulated cellular oxidative damage, affects<br />

more than 40% of <strong>American</strong>s over age 65. The mitochondrial<br />

deacetylase SIRT3 improves antioxidant defenses by activating isocitrate<br />

dehydrogenase 2, thereby increasing the reduced-to-oxidized glutathione<br />

ratio. Oxidative stress induces autophagy, a process by which<br />

cells degrade and recycle their contents to preserve cellular health.The<br />

precise molecular mechanisms by which cells respond to oxidative<br />

stress and induce autophagy via SIRT3 have not yet been elucidated.<br />

Methods: We investigated the role of SIRT3 in regulating autophagy<br />

in model systems. We used inner ears, brain, heart, and fibroblasts<br />

from wild type (WT), SIRT3-overexpressing, and Little<br />

mice (have 40% longer lifespan and reduced oxidative stress). Experiments<br />

included activation and inhibition of autophagy and expression<br />

of SIRT3 to determine its potential role in SIRT3-dependent<br />

protective mechanisms against cellular damage and AHL.<br />

Results: The average SIRT3 levels were increased 18% in 24-<br />

month-old WT mice and increased 628% in 24—month-old Little mice,<br />

compared to their 4-month-old littermate controls.When SIRT3 levels<br />

were depleted in WT fibroblasts using siRNA, autophagy was activated<br />

as measured by LC3-II/LC3-I ratio. After an 18- or 24-hour treatment<br />

with 100nM rapamycin, autophagy levels also increased 1.8-fold while<br />

SIRT3 levels decreased 1.37-fold.Activating autophagy by 2 or 4 hours<br />

of starvation increased activation 8.35-fold and SIRT3 levels decreased<br />

3.9-fold. Inhibiting autophagy with 50uM Wortmannin for 2 or 4 hours<br />

decreased autophagy 2.78-fold and increased SIRT3 levels 1.35-fold.<br />

Conclusion: These preliminary results suggest autophagy is<br />

linked to SIRT3: increased SIRT3 is associated with improved oxidative<br />

protection and decreased autophagy and vice versa. These findings<br />

may provide therapeutic insight into rational drug design of new<br />

medications that activate SIRT3 or autophagy for the prevention of<br />

age-related hearing loss and to improve health span.<br />

P18 Encore Presentation<br />

Lipid-depleted apolipoproteins and amyloid peptides are influenced<br />

by APOE genotype and cognitive diagnosis.<br />

A. J. Hanson, 1,2 J. L. Bayer-Carter, 1,2 P. S. Green, 1,2 T. J. Montine, 1,2<br />

L. D. Baker, 1,2 G. S. Watson, 1,2 L. M. Bonner, 2 M. Callaghan, 2<br />

J. B. Leverenz, 1,2 B. K. Walter, 2 E. C. Tsai, 1,2 C. W. Wilkinson, 1,2<br />

J. Zhang, 1 S. Craft. 1,2 1. University of Washington Medical Center,<br />

Seattle, WA; 2. GRECC, VA Puget Sound Health Care System,<br />

Seattle, WA.<br />

Supported By: T32 AG-000258-13 to Dr. Hanson, R37 AG-10880<br />

from NIA to Dr Craft, P50 AG-05136 to Dr. Montine.<br />

BACKGROUND: Sporadic Alzheimer’s disease (AD) is caused<br />

in part by decreased clearance of the Aβ amyloid breakdown products.<br />

Apolipoproteins play an important yet unclear role in Aβ peptide<br />

clearance, particularly ApoE since its E4 variant is a risk factor<br />

for AD. Work in cell culture and animal models have shown that<br />

lipid-depleted apolipoproteins are less effective at binding Aβ, and<br />

that lipoprotein-depleted (LD) fractions of Aβ peptides are more<br />

toxic to neurons. However, not much is known about the lipid states<br />

of these proteins in human CSF.<br />

METHODS: Cerebrospinal fluid (CSF) was obtained from 20<br />

participants with normal cognition (mean age 69 ± 7) and 27 with<br />

amnestic mild cognitive impairment (MCI) (mean age 67 ± 6). We determined<br />

the APOE genotype status of each participant. Lipid-depleted<br />

ApoE and ApoJ and lipoprotein-depleted Aβ peptides were<br />

separated by density gradient ultracentrifugation and levels were<br />

then measured by ELISA. Groups were compared using analysis of<br />

covariance.<br />

RESULTS: Subjects with an APOE ε4 allele (E4+) had higher<br />

lipid-depleted ApoE levels, for both normal and MCI groups<br />

(p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!